NYSE:ELVHealthcare
A Look At Elevance Health (ELV) Valuation After Its Q1 2026 Earnings Beat And Guidance Raise
Elevance Health (ELV) is back in focus after its Q1 2026 earnings topped revenue and adjusted EPS expectations. The company also lifted full year EPS guidance and highlighted firm medical cost control.
See our latest analysis for Elevance Health.
The Q1 beat and higher guidance arrive after a sharp 19.6% 1 month share price return and a 10% 3 month share price return. However, the 1 year total shareholder return of a 7.6% decline and 3 year total shareholder return of a 14.3% decline indicate...